Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 24, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for April 12, 2005 Subscribe to this News Feed      
 

Yet Another Arthritis Drug Banned by the FDA- Naturopathic Medicine Offers Options to the 66 Million Arthritis Sufferers

Physician explores natural alternatives to recently banned medications.

Phoenix, AZ (PRWEB) April 12, 2005 -- With yet another prescription arthritis drug banned by the FDA, consumers are confused as to the available options. Many over-the-counter drugs taken as alternatives to recalled medications have now been required by the FDA to list extra warnings for risk of cardiovascular events, leaving the 1 in 3 Americans with arthritis wondering what their alternatives are for treatment. Naturopathic medicine can offer effective natural alternatives for people desiring options for their pain.

Bextra, the latest drug banned by the FDA, belongs to a class of drugs called cyclooxygenase (COX) inhibitors, along with Vioxx, Celebrex, and NSAIDs. Cyclooxygenase is an enzyme associated with inflammation, and drugs were developed to address the pain and inflammation associated with arthritis conditions. COX also serves an important factor in regulating the clotting mechanism of blood. Inhibition of this enzyme has proven to be associated with cardiovascular event risk such as heart attacks and strokes which prompted the FDA action.

It is estimated that 66 million Americans suffer from chronic joint conditions such as arthritis, up from 43 million in 1998. With 36% of adults using some form of alternative medicine, it is important to note the options that Naturopathic Medicine offers for arthritis sufferers.

According to David A. Tallman DC, ND, a naturopathic physician in Scottsdale, Arizona whose practice is dedicated to arthritis and joint disease, natural anti-inflammatory medications have been used for a long time to palliate pain," says Tallman. Proteolytic enzymes for example are well studied and have proven efficacy as an anti-inflammatory. The amino acid S-adenosylmethionine (SAMe) has been shown to be as effective as Celebrex for palliation of arthritis pain and has proven anti-depressant effects, with no known toxicity."

Dr. Tallman utilizes regenerative injection therapy (RIT) in addition to these natural medicines to address the causality of pain and degeneration.

Before starting on a regimen, be sure to seek advice from a licensed physician trained in natural medicine. Although nutritional supplements and herbs can be powerful medications," states Tallman, it is important not to self-prescribe any medications, either pharmaceutical or natural." When used correctly, natural medicine and therapies such as RIT can offer significant relief for those in search of alternatives to COX 1 and 2 inhibitors.

Photos available: before and after X rays of arthritic joints treated with RIT and naturopathic medicine

Patients treated with natural medicine for arthritis available for comment

###

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Dr. David A. Tallman
Arthritis Research
480-951-0111
Email us Here
ATTACHED FILES

Before and After x-rays
65 year old female treated by Dr. David A. Tallman for osteoarthritis of right knee. Treatment included prolotherapy and naturopathic medicine.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright